01Available sources
The milestone
The FDA approves trastuzumab for HER2-positive metastatic breast cancer.
Sources for this section
- Milestones in Cancer Research and DiscoveryNational Cancer Institute / NIH
LIMITATIONS AND CONTEXT
The scope of this reading
- A historical record limited to the cited event; it does not represent a current care recommendation.
- Discovery, clinical assessment, regulatory approval and access in practice are different stages.
ORIGINAL READING
References and sources
- Milestones in Cancer Research and DiscoveryNational Cancer Institute / NIH
- National Cancer Institute